Upsher-Smith

Maple Grove, United States Founded: 1919 • Age: 107 yrs Acquired By Bora Pharmaceuticals
Manufacturer of generic drugs

About Upsher-Smith

Upsher-Smith is a company based in Maple Grove (United States) founded in 1919 was acquired by Bora Pharmaceuticals in January 2024. The company has 587 employees. Upsher-Smith has completed 1 acquisition, including Proximagen.

  • Headquarter Maple Grove, United States
  • Employees 587
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website upsher-smith.com
  • Social Facebook
  • Acquired by Sawai (Apr 2017)
  • Legal Name Upsher-Smith Laboratories, Llc
Key Metrics

Investors in Upsher-Smith

Upsher-Smith has secured backing from 2 investors. Prominent investors backing the company include Sawai and Bora Pharmaceuticals.

All
InvestorDescriptionFounded YearDomainLocation
Developer of generic pharmaceuticals and a PHR management app
1929sawai.co.jpOsaka, Japan
Traditional pharma company manufacturing and marketing a range of pharmaceutical products
2008bora-corp.comTaipei, Taiwan
Premium access

Investor details for Upsher-Smith

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Upsher-Smith

72 people are tracked at Upsher-Smith (16 in leadership, 1 in board & advisors, 55 in team); the tracked headcount is 587.

NameRoleGroup
Jerusha Thompson
Associate Director Of Project ManagementLeadership
Ashish Jaiswal
Associate DirectorLeadership
Lori Riggs
Sr. Procurement Specialist, CMOLeadership
Larry Patterson
Director, Operations Special ProjecLeadership
Stephanie Fleitman
Associate Director, Regional AccountsLeadership
Bryan Neisen
Director, EngineeringLeadership
Ryan Urbach
Director IT Infrastructure And Enterprise SecurityLeadership
Patricia Bergman
Director, Human ResourcesLeadership
Gloria Davis
Materials Management & Supply Planning DirectorLeadership
Jarrod Midboe
Director, Clinical Affairs And Vendor/alliance ManagementLeadership
Jonas Skjei
Associate Director Quality Compliance And Computerized Systems ValidationLeadership
Jim Maahs
Svp, Head Of Upsher-smith CommercialLeadership
Anthony J. Bellotte
Director Of Supply Chain And ProcurementLeadership
Ramin Rigi
Director Human ResourcesLeadership
Sarah Shannon
Sr. Director Commercial Strategy & OperationsLeadership
Becky Jansen
Associate Vice PresidentLeadership
Masahiro Sasaki
ChairmanBoard & advisors
Phillippa Scott
Sales Operations SpecialistTeam
Jessica Wise
Manager, Commercial Pricing & AnalyticsTeam
Katheriner Hogue
Contract RecruiterTeam

52 more people are available in the full profile.

Premium access

Complete people profiles for Upsher-Smith

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Upsher-Smith

Upsher-Smith has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Proximagen.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Small molecules for neurodegenerative disorders, including Parkinson’s and Alzheimers.
proximagen.comLondon, United Kingdom2004Jun 2012$555M
Premium access

Complete acquisition details for Upsher-Smith

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Upsher-Smith

4 dated milestones of Upsher-Smith across 105 years, from founding to its latest funding, stage changes and deals.

  1. Founded Upsher-Smith is founded.
  2. Acquisition Acquires Proximagen.
  3. Exit Acquired by Sawai.
  4. Exit Acquired by Bora Pharmaceuticals.

Web traffic of Upsher-Smith

The website of Upsher-Smith (upsher-smith.com) receives about 12K visits a month and ranks #3,083,070 among all websites worldwide, #4,072 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    12K

    ▲ 81.8% vs previous month

  • Unique visitors
    3K

    per month

  • Global rank
    #3,083,070

    among all websites

  • Category rank
    #4,072

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Upsher-Smith. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cimalabs.com
cimalabs.com
100%
–––
accerapharma.com
accerapharma.com
80%
–––
salix.com
78%
15.6K#1,433,848View details
versapharm.com
77%
––View details
alkemlabs.com
76%
30.3K–View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for Upsher-Smith

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Upsher-Smith

Premium access

Complete news archive for Upsher-Smith

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Upsher-Smith

10 companies that operate in the same segment as Upsher-Smith (Traditional Health & Nutrition), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United States–USD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United States–USD 5.1 B13,500
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
1901Petah Tikva, Central District, IsraelUSD 500 MUSD 18.74 B51,792
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, India–USD 508.93 M5,180
Pharmaceutical products are developed and marketed globally.
2009Montville, New Jersey, United StatesUSD 155.92 M––
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, India–USD 6.21 B25,870
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations
1991Delhi, Delhi, IndiaUSD 367.2 MUSD 1.52 B21,320
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt.
1967Mumbai, Maharashtra, India–USD 353.53 M3,410
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Upsher-Smith

Upsher-Smith was founded in 1919.

Upsher-Smith is headquartered in Maple Grove, United States. It is registered at Maple Grove, Minnesota, United States.

Upsher-Smith has 587 employees.

Upsher-Smith, founded in 1919 in Maple Grove, United States, focuses on providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of generic drugs. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Upsher-Smith has made 1 acquisition, including Proximagen.

Upsher-Smith has 2 investors. Key investors include Sawai, and Bora Pharmaceuticals.

Upsher-Smith operates through Upsher-Smith Laboratories, Llc.

Yes. Upsher-Smith was acquired by Sawai in April 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available